At GleneaglesCRC we have the investigative site networks, large treatment-naive patient pools, efficient regulatory submissions timelines, and global data quality standards, to ensure that the unique requirements of your project are met and exceeded. We look forward to collaborating with you!
GleneaglesCRC is a premier full service CRO in the Asian-Australasian region, a joint venture of ParkwayHealth (Asia’s largest private healthcare network) and Mitsui Co. Ltd.
GleneaglesCRC has branch offices in eight countries: Singapore, China, Thailand, the Philippines, Indonesia, Australia, India and South Korea ( Taiwan and Japan by end 2010 ). GleneaglesCRC’s key strength is in providing local solution to companies for their global drug development across all therapeutic areas and in a diversified regulatory environment.
GleneaglesCRC has privileged access to all of ParkwayHealth’s doctors and hospitals ( including our investor’s hospital, in total 62 hospitals ) for example, Gleneagles Hospital, Mt Elizabeth Hospital, and Parkway East Hospital located in Singapore; Gleneagles Intan, in Kuala Lumpur; Gleneagles Medical Penang, Malaysia; and the entire Pantai Group of Hospitals in Malaysial the Apollo Gleneagles Hospital in Kolkatta, India and the Fortis group of hospitals in India; and the Gleneagles JPMC Brunei Cardiac Centre.
In addition to these sites, GleneaglesCRC has also worked with over 300 different hospital sites and 1000 investigators across 12 countries in Asia.
Copyright © 2011 - GleneaglesCRC Pte Ltd - All rights reserved.